Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Phytother Res ; 30(2): 272-82, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26668123

ABSTRACT

Emergence of worldwide antimicrobial resistance prompted us to study the resistance modifying potential of plant-derived dietary polyphenols, mainly caffeic acid, ellagic acid, epigallocatechin-3-gallate (EGCG) and quercetin. These compounds were studied in logical combination with clinically significant antibiotics (ciprofloxacin/gentamicin/tetracycline) against Klebsiella pneumoniae, after conducting phenotypic screening of a large number of clinical isolates and selecting the relevant strains possessing extended-spectrum ß-lactamase (ESBL) and K. pneumoniae carbapenemase (KPC)-type carbapenemase enzymes only. The study demonstrated that EGCG and caffeic acid could synergize the activity of tested antibiotics within a major population of ß-lactamase-producing K. pneumoniae. In spectrofluorimetric assay, ~17-fold greater ciprofloxacin accumulation was observed within K. pneumoniae cells pre-treated with EGCG in comparison with the untreated control, indicating its ability to synergize ciprofloxacin to restrain active drug-efflux. Further, electron micrograph of ESBL-producing K. pneumoniae clearly demonstrated the prospective efficacy of EGCG towards biofilm degradation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Klebsiella pneumoniae/drug effects , Phytochemicals/pharmacology , Polyphenols/pharmacology , Bacterial Proteins/metabolism , Caffeic Acids/pharmacology , Catechin/analogs & derivatives , Catechin/pharmacology , Ciprofloxacin/pharmacology , Drug Synergism , Ellagic Acid/pharmacology , Gentamicins/pharmacology , Klebsiella pneumoniae/enzymology , Microbial Sensitivity Tests , Quercetin/pharmacology , Reserpine/pharmacology , Tetracycline/pharmacology , beta-Lactamases/metabolism
2.
Invest New Drugs ; 33(1): 22-31, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25262983

ABSTRACT

Anticancer activity of diospyrin and its derivatives (1-5) was evaluated against thirteen human cell lines. Compared to diospyrin (1), the acetylamine derivative (4) exhibited increase in cytotoxicity, particularly in HT-29 colon cancer cells, showing GI50 values of 33.90 and 1.96 µM, respectively. Also, enhanced toxicity was observed when cells, pre-treated with compound 4, were exposed to radiation. In vivo assessment of 4 was undertaken on tumour-bearing Nod-Scid mice treated at 4 mg/kg/day. Significant reduction in relative tumour volume (~86-91 %) was observed during the 12th-37th days after drug treatment. Increased caspase-3 activity and DNA ladder formation was observed in HT-29 cells after treatment with 4, suggesting induction of apoptotic death after drug treatment. Moreover, flow cytometric determination of Annexin V- FITC positive and PI negative cells demonstrated 17.4, 26.4, and 27.9 % of early apoptosis, respectively, upon treatment with 5, 10 and 25 µM of 4. HT-29 cells after treatment with 4 (1-25 µM) revealed ~2.5- 3- folds generation of ROS. Furthermore, concentration dependent decrease of mitochondrial trans-membrane potential (∆ψm), and expression of Bcl-2/Bax and other marker proteins suggested involvement of mitochondrial pathway of cell death. Overall, our results demonstrated the underlying cell-death mechanism of the plant-derived naphthoquinonoid (4), and established it as a prospective chemotherapeutic 'lead' molecule against colon cancer.


Subject(s)
Antineoplastic Agents, Phytogenic/therapeutic use , Colonic Neoplasms/drug therapy , Naphthoquinones/therapeutic use , Animals , Antineoplastic Agents, Phytogenic/pharmacology , Caspase 3/metabolism , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Proliferation/radiation effects , Cell Survival/drug effects , Colonic Neoplasms/pathology , DNA Fragmentation , Humans , Membrane Potential, Mitochondrial , Mice, Inbred NOD , Mice, SCID , Naphthoquinones/pharmacology , Tumor Burden/drug effects , Xenograft Model Antitumor Assays
3.
Exp Parasitol ; 135(2): 407-13, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23973194

ABSTRACT

World health organization has called for academic research and development of new chemotherapeutic strategies to overcome the emerging resistance and side effects exhibited by the drugs currently used against leishmaniasis. Diospyrin, a bis-naphthoquinone isolated from Diospyros montana Roxb., and its semi-synthetic derivatives, were reported for inhibitory activity against protozoan parasites including Leishmania. Presently, we have investigated the antileishmanial effect of a di-epoxide derivative of diospyrin (D17), both in vitro and in vivo. Further, the safety profile of D17 was established by testing its toxicity against normal macrophage cells (IC50∼20.7 µM), and also against normal BALB/c mice in vivo. The compound showed enhanced activity (IC50∼7.2 µM) as compared to diospyrin (IC50∼12.6 µM) against Leishmania donovani promastigotes. Again, D17 was tested on L. donovani BHU1216 isolated from a sodium stibogluconate-unresponsive patient, and exhibited selective inhibition of the intracellular amastigotes (IC50∼0.18 µM). Also, treatment of infected BALB/c mice with D17 at 2mg/kg/day reduced the hepatic parasite load by about 38%. Subsequently, computational docking studies were undertaken on selected enzymes of trypanothione metabolism, viz. trypanothione reductase (TryR) and ornithine decarboxylase (ODC), followed by the enzyme kinetics, where D17 demonstrated non-competitive inhibition of the L. donovani ODC, but could not inhibit TryR.


Subject(s)
Antiprotozoal Agents/pharmacology , Leishmania donovani/drug effects , Naphthoquinones/pharmacology , Ornithine Decarboxylase/drug effects , Animals , Antiprotozoal Agents/toxicity , Cell Line , Female , Gene Expression Regulation, Enzymologic/drug effects , Inhibitory Concentration 50 , Kidney/drug effects , Kidney/enzymology , Leishmania donovani/enzymology , Leishmania donovani/genetics , Liver/drug effects , Liver/enzymology , Macrophages/drug effects , Mice , Mice, Inbred BALB C , Naphthoquinones/chemistry , Naphthoquinones/toxicity , Ornithine Decarboxylase/genetics , Ornithine Decarboxylase/metabolism , Ornithine Decarboxylase Inhibitors , Random Allocation
4.
Food Chem Toxicol ; 59: 485-91, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23827777

ABSTRACT

Nymphaea pubescens Willd. is used as ingredient of ethnic diet and folk medicine in South-East Asia. The water (NPW), methanol (NPM) and chloroform (NPC) extracts of N. pubescens flowers were investigated for NO·, O2·â» and DPPH radical scavenging and iron chelating activities in vitro. NPW was found to be the most potent free radical scavenger (EC50<100 µg/mL) whereas NPC did not show EC50 at 500 µg/mL. Therefore, NPW was selected for further studies on anti-inflammatory and hepatoprotective activities, using standard in vitro and in vivo models. NPW exhibited inhibition of nitrogen radical generation in LPS-activated macrophages (IC50=75.5 µg/mL) through suppression of iNOS protein, with no associated toxicity in the cells. Further, 500 mg/kg of NPW reduced rat paw edema by ~50% after 6h of carrageenan administration. Hepatoprotective activity of NPW was also evaluated in vivo on CCl4-induced hepatotoxicity model in rats. NPW treatment (500 mg/kg/day for ten days) attenuated CCl4-induced increase in serum enzymes, viz. alanine and aspartate aminotransferases (ALT and AST) and bilirubin. Also, glutathione and superoxide dismutase (SOD)-levels were restored towards normalcy in the liver of CCl4-treated rats, indicating the hepatoprotective role of NPW, which was found to contain a fair amount of flavonoids, phenolics, and saponin constituents.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Carbon Tetrachloride Poisoning/prevention & control , Dietary Supplements , Flowers/chemistry , Free Radical Scavengers/therapeutic use , Nymphaea/chemistry , Plant Extracts/therapeutic use , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Anti-Inflammatory Agents, Non-Steroidal/isolation & purification , Anti-Inflammatory Agents, Non-Steroidal/metabolism , Carbon Tetrachloride Poisoning/blood , Carbon Tetrachloride Poisoning/immunology , Carbon Tetrachloride Poisoning/metabolism , Cells, Cultured , Chelating Agents/isolation & purification , Chelating Agents/metabolism , Chelating Agents/therapeutic use , Dietary Supplements/analysis , Edema/immunology , Edema/metabolism , Edema/prevention & control , Ethnopharmacology , Flavonoids/administration & dosage , Flavonoids/isolation & purification , Flavonoids/metabolism , Flavonoids/therapeutic use , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/isolation & purification , Free Radical Scavengers/metabolism , India , Liver/drug effects , Liver/immunology , Liver/metabolism , Macrophages/cytology , Macrophages/immunology , Macrophages/metabolism , Mice , Phenols/administration & dosage , Phenols/isolation & purification , Phenols/metabolism , Phenols/therapeutic use , Plant Extracts/administration & dosage , Plant Extracts/isolation & purification , Plant Extracts/metabolism , Random Allocation , Rats , Saponins/administration & dosage , Saponins/isolation & purification , Saponins/metabolism , Saponins/therapeutic use , Subcutaneous Tissue/immunology , Subcutaneous Tissue/metabolism
5.
Food Chem Toxicol ; 50(12): 4302-9, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22982804

ABSTRACT

A methanolic extract of Punica granatum (pomegranate) fruit pericarp (PGME) was tested in combination with ciprofloxacin against extended-spectrum ß-lactamase (ESBL) producing Escherichia coli, Klebsiella pneumoniae, and metallo-ß-lactamase (MBL) producing Pseudomonas aeruginosa, which were screened for their resistance profile against fluoroquinolone antibiotics. The minimum inhibitory concentrations (MIC) of ciprofloxacin and PGME, alone, were determined, and synergy of ciprofloxacin-PGME combinations evaluated by checkerboard assay and fractional inhibitory concentration (FIC). Nineteen out of forty-nine strains exhibited synergy with ciprofloxacin (FIC of 0.125-0.5 for ciprofloxacin) further verified by agar-well assay. This could be due to the bacterial efflux pump inhibitor (EPI) activity of the polyphenolic constituents of PGME. However, the isolates exhibiting a high level of ciprofloxacin resistance did not respond to ciprofloxacin-PGME combinations, which could be due to target site modification not influenced further by EPI activity of PGME. Again, some strains were sensitive or weakly resistant to ciprofloxacin, which exhibited 'indifference' to the combination, probably due to a lack of over-expressed efflux mechanism. Thus, a synergy of a ciprofloxacin-PGME combination was demonstrated for the first time against ESBL- and MBL-producing Gram-negative bacilli, and the efficacy of an existing drug improved with the help of an inexpensive alternative therapy.


Subject(s)
Anti-Bacterial Agents/pharmacology , Ciprofloxacin/pharmacology , Lythraceae/chemistry , Plant Extracts/pharmacology , Drug Resistance, Bacterial/drug effects , Drug Synergism , Escherichia coli/drug effects , Flavonoids/analysis , Fluoroquinolones/pharmacology , Klebsiella pneumoniae/drug effects , Microbial Sensitivity Tests , Plant Extracts/analysis , Polyphenols/analysis , Pseudomonas aeruginosa/drug effects , beta-Lactamases/metabolism
6.
Parasitol Res ; 111(1): 195-203, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22297912

ABSTRACT

Cryptolepine (5-methyl-10H-indolo [3, 2-b] quinoline), an indoloquinoline alkaloid (1) isolated from a medicinal plant traditionally used in Western Africa for treatment of malaria, has been shown to possess broad spectrum biological activity in addition to its antiplasmodial effect. Here, the antileishmanial properties of 11 synthetic derivatives of cryptolepine against Leishmania donovani parasites have been evaluated for the first time. 2,7-Dibromocryptolepine (8; IC50 0.5 ± 0.1 µM) was found to be the most active analogue against the promastigote form of a classical L. donovani strain (AG83) in comparison to the natural alkaloid, cryptolepine (1; IC50 1.6 ± 0.1 µM). Further, 8 was found to substantially inhibit the intracellular amastigote forms of two clinical isolates, one of them being an SbV-resistant strain of L. donovani. Moreover, the toxicity of 8 against normal mouse peritoneal macrophage cells was markedly lower than that of 1 (IC50 values: 9.0 ± 1.2 and 1.1 ± 0.3 µM, respectively), indicating 8 to be a prospective "lead" towards novel antileishmanial therapy. This was supported by studies on the mechanism of cytotoxicity induced by 8 in L. donovani promastigotes (AG83), which revealed the cytoplasmic and nuclear features of metazoan apoptosis. Light microscopic observation demonstrated a gradual decline in the motility, cell volume, and survival of the treated parasites with increasing incubation time. Flow cytometric analysis of phosphatidylserine externalization and distribution of cells in different phases of cell cycle confirmed the presence of a substantial percentage of cells in early apoptotic stage. Disruption of mitochondrial membrane integrity in terms of depolarization of membrane potential, and finally degradation of chromosomal DNA into oligonucleosomal fragments - the hallmark event of apoptosis - characterized the mode of cell death in L. donovani promastigotes.


Subject(s)
Alkaloids/pharmacology , Antiprotozoal Agents/pharmacology , Indoles/pharmacology , Leishmania donovani/drug effects , Quinolines/pharmacology , Africa, Western , Alkaloids/isolation & purification , Alkaloids/toxicity , Animals , Antiprotozoal Agents/isolation & purification , Antiprotozoal Agents/toxicity , Cell Survival/drug effects , Cells, Cultured , Female , Indoles/isolation & purification , Indoles/toxicity , Inhibitory Concentration 50 , Leishmania donovani/cytology , Leishmania donovani/physiology , Macrophages/drug effects , Macrophages/parasitology , Mice , Mice, Inbred BALB C , Microscopy , Plants, Medicinal/chemistry , Quinolines/isolation & purification , Quinolines/toxicity
7.
Biochem Biophys Res Commun ; 417(2): 903-9, 2012 Jan 13.
Article in English | MEDLINE | ID: mdl-22209849

ABSTRACT

Diospyrin diethylether (D7), a bisnaphthoquinonoid derivative, exhibited an oxidative stress-dependent apoptosis in several human cancer cells and tumor models. The present study was aimed at evaluation of the increase in cytosolic calcium [Ca(2+)](c) leading to the apoptotic cell death triggered by D7 in MCF7 human breast carcinoma cells. A phosphotidylcholine-specific phospholipase C (PC-PLC) inhibitor, viz. U73122, and an antioxidant, viz. N-acetylcysteine, could significantly prevent the D7-induced rise in [Ca(2+)](c) and PC-PLC activity. Using an endoplasmic reticulum (ER)-Ca(2+) mobilizer (thapsigargin) and an ER-IP3R antagonist (heparin), results revealed ER as a major source of [Ca(2+)](c) which led to the activation of calpain and caspase12, and cleavage of fodrin. These effects including apoptosis were significantly inhibited by the pretreatment of Bapta-AM (a cell permeable Ca(2+)-specific chelator), or calpeptin (a calpain inhibitor). Furthermore, D7-induced [Ca(2+)](c) was found to alter mitochondrial membrane potential and induce cytochrome c release, which was inhibited by either Bapta-AM or ruthenium red (an inhibitor of mitochondrial Ca(2+) uniporter). Thus, these results provided a deeper insight into the D7-induced redox signaling which eventually integrated the calcium-dependent calpain/caspase12 activation and mitochondrial alterations to accentuate the induction of apoptotic cell death.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Breast Neoplasms/metabolism , Calcium/metabolism , Carcinoma/metabolism , Endoplasmic Reticulum/drug effects , Mitochondria/drug effects , Naphthoquinones/pharmacology , Acetylcysteine/pharmacology , Calcium Channels/metabolism , Cell Line, Tumor , Chelating Agents/pharmacology , Cytosol/metabolism , Egtazic Acid/analogs & derivatives , Egtazic Acid/pharmacology , Endoplasmic Reticulum/metabolism , Estrenes/pharmacology , Female , Humans , Mitochondria/metabolism , Oxidation-Reduction/drug effects , Phosphodiesterase Inhibitors/pharmacology , Pyrrolidinones/pharmacology , Ruthenium Red/pharmacology , Type C Phospholipases/antagonists & inhibitors , Type C Phospholipases/metabolism
8.
Parasitol Res ; 108(4): 861-71, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21085992

ABSTRACT

Leishmanial diseases, posing a public health problem worldwide, are caused by Leishmania parasites with a dimorphic life cycle alternating between the promastigote and amastigote forms. Promastigotes transmitted by the vector are transformed into amastigotes residing in the host tissue macrophages. Presently, new antiparasitic agents are needed against Leishmania donovani and Leishmania major, the respective organisms causing visceral and cutaneous leishmaniasis, since the available treatments are unsatisfactory due to toxicity, high cost, and emerging drug resistance. Over the years, traditional medicinal flora throughout the world enriched the modern pharmacopeia. Hence, roots of 'Indian Valerian' (Valeriana wallichii DC) were studied for its antileishmanial activity for the first time. The methanol and chloroform extracts showed activity against L. donovani promastigotes and both promastigotes and amastigotes of L. major. The most active fraction, F3, obtained from the chloroform extract, showed IC(50) at ∼ 3-7 µg/ml against both the promastigotes and 0.3 µg/ml against L. major amastigotes. On investigation of the mechanism of cytotoxicity in L. donovani promastigotes, the 'hall-mark' events of morphological degeneration, DNA fragmentation, externalization of phosphatidyl serine, and mitochondrial membrane depolarization indicated that F3 could induce apoptotic death in leishmanial cells. Therefore, the present study revealed a novel and unconventional property of V. wallichii root as a prospective source of effective antileishmanial agents.


Subject(s)
Antiprotozoal Agents/pharmacology , Leishmania donovani/drug effects , Leishmania major/drug effects , Plant Extracts/pharmacology , Valerian/chemistry , Antiprotozoal Agents/isolation & purification , Apoptosis , Inhibitory Concentration 50 , Parasitic Sensitivity Tests , Plant Extracts/isolation & purification , Plant Roots/chemistry
9.
Front Pharmacol ; 2: 94, 2011.
Article in English | MEDLINE | ID: mdl-22291649

ABSTRACT

Treatment of cancer often requires exposure to radiation, which has several limitations involving non-specific toxicity toward normal cells, reducing the efficacy of treatment. Efforts are going on to find chemical compounds which would effectively offer protection to the normal tissues after radiation exposure during radiotherapy of cancer. In this regard, plant-derived compounds might serve as "leads" to design ideal radioprotectors/radiosensitizers. This article reviews some of the recent findings on prospective medicinal plants, phytochemicals, and their analogs, based on both in vitro and in vivo tumor models especially focused with relevance to cancer radiotherapy. Also, pertinent discussion has been presented on the molecular mechanism of apoptotic death in relation to the oxidative stress in cancer cells induced by some of these plant samples and their active constituents.

10.
J Pharm Pharmacol ; 62(9): 1158-66, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20796195

ABSTRACT

OBJECTIVES: The aim was to search for anti-inflammatory and anticancer compounds from three medicinal plants, viz. Ventilago madraspatana Gaertn., Rubia cordifolia Linn. and Lantana camara Linn. METHODS: The NO* scavenging potential of selected plant extracts was determined on LPS/IFN-gamma activated murine peritoneal macrophage cultures, and iNOS and COX-2 expression was evaluated by Western blot analysis. Bio-assay guided fractionation yielded four compounds: physcion and emodin from V. madraspatana, 1-hydroxytectoquinone from R. cordifolia, and oleanonic acid from L. camara. The anti-inflammatory activity of these compounds was tested through the carrageenan-induced rat-paw oedema model. They were then tested against a murine tumour (Ehrlich ascites carcinoma), and three human cancer cell lines, namely A375 (malignant skin melanoma), Hep2 (epidermoid laryngeal carcinoma) and U937 (lymphoma). KEY FINDINGS: All four compounds dose dependently inhibited NO* through suppression of iNOS protein without affecting macrophage viability. Physcion and emodin caused 65-68% reduction of oedema volume at 40 mg/kg, which validated their in-vivo anti-inflammatory effect. 1-Hydroxytectoquinone and oleanonic acid exhibited promising cytotoxicity against A375 cells. CONCLUSIONS: Ethnomedical reports on these traditional medicinal plants have been rationalised through an insight into the anti-inflammatory as well as anticancer potential of four constituents, characterised to be prospective candidates for designing novel therapeutic agents.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Antineoplastic Agents, Phytogenic/pharmacology , Lantana/chemistry , Nitric Oxide/metabolism , Plant Extracts/pharmacology , Quinones/pharmacology , Rhamnaceae/chemistry , Rubia/chemistry , Animals , Anti-Inflammatory Agents/isolation & purification , Anti-Inflammatory Agents/therapeutic use , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/therapeutic use , Antioxidants/pharmacology , Antioxidants/therapeutic use , Carrageenan , Cell Line, Tumor , Disease Models, Animal , Dose-Response Relationship, Drug , Edema/drug therapy , Edema/metabolism , Free Radicals/metabolism , Humans , Interferon-gamma , Lipopolysaccharides , Macrophages/drug effects , Mice , Neoplasms/drug therapy , Neoplasms/metabolism , Nitric Oxide Synthase Type II/antagonists & inhibitors , Phytotherapy , Plant Extracts/therapeutic use , Quinones/isolation & purification , Quinones/therapeutic use
11.
Int J Antimicrob Agents ; 34(6): 596-601, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19783125

ABSTRACT

Previous studies have demonstrated that diospyrin (1), a quinonoid plant product, can inhibit the growth of Leishmania donovani parasites. Here, several derivatives of 1 were evaluated by the MTT assay and it was observed that the ethanolamine analogue (10) exhibited maximum cytotoxicity [50% inhibitory concentration (IC(50))=2.9 microM] against L. donovani promastigotes. Subsequently, the mode of cell death in promastigotes was investigated through externalisation of membrane-associated phosphatidylserine, mitochondrial membrane depolarisation, DNA laddering and in situ labelling of DNA fragmentation by terminal deoxyribonucleotidyl transferase-mediated dUTP nick-end labelling (TUNEL) methods. Whilst both 1 and 10 were found to induce apoptosis-like death in promastigotes, the effect of 10 was evidently stronger even at a lower concentration. Hence, the ethanolamine derivative (10) of diospyrin (1) may be a prospective 'lead' for the development of novel cytotoxic agents inducing apoptosis in L. donovani parasites.


Subject(s)
Antiprotozoal Agents/pharmacology , Apoptosis , Ethanolamines/pharmacology , Leishmania donovani/drug effects , Naphthoquinones/pharmacology , Animals , DNA Fragmentation , Ethanolamines/chemistry , Inhibitory Concentration 50 , Naphthoquinones/chemistry , Parasitic Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...